Supra ventricular tachycardia short notes in paediatrics With reference nelson

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Loading Image
Reading File
Reading File
Reading File
Loading Image
I now have comprehensive content from multiple authoritative sources. Let me compile the detailed short notes on SVT in paediatrics.

Supraventricular Tachycardia (SVT) in Paediatrics

Short Notes - with reference to Nelson's Textbook of Paediatrics

Note on sources: Nelson's Textbook of Paediatrics is not directly available in this library. The notes below are compiled from equivalent authoritative paediatric references - Rosen's Emergency Medicine (Paediatric Cardiac chapter), The Harriet Lane Handbook (Johns Hopkins, 23rd ed.), and Tintinalli's Emergency Medicine - which align with Nelson's content on this topic.

Definition

SVT is any tachyarrhythmia that originates at or above the bundle of His, with the impulse not originating from the sinus node. It is the most common symptomatic dysrhythmia in infants and children.

Epidemiology

  • No cardiac abnormalities are found in approximately 50% of cases
  • Wolff-Parkinson-White (WPW) syndrome is found in only 10-20% of paediatric SVT
  • Associated congenital heart disease includes Ebstein's anomaly and corrected transposition of the great arteries
  • WPW prevalence: 0.1 to 3.1 per 1000; more common in boys

Mechanisms / Classification

The most common SVT in infants and children is atrioventricular reentrant tachycardia (AVRT) - a reentrant mechanism using an accessory pathway + AV node.

1. Orthodromic AVRT (most common - narrow complex)

  • Antegrade conduction: Atria → AV node → Ventricles (normal path)
  • Retrograde conduction: Ventricles → Atria via accessory pathway
  • Produces a narrow-QRS complex SVT

2. Antidromic AVRT (less common - wide complex)

  • Antegrade conduction: Atria → Accessory pathway → Ventricles
  • Retrograde: via AV node
  • Produces a wide-QRS complex SVT

3. Other causes

  • Atrioventricular nodal reentrant tachycardia (AVNRT)
  • Atrial flutter / atrial fibrillation
  • Automatic (ectopic) atrial tachycardia
  • Junctional ectopic tachycardia (especially post-cardiac surgery)

Clinical Features

Infants

  • Irritability, poor feeding, pallor
  • Respiratory distress, tachypnea
  • Signs of congestive heart failure (CHF) if prolonged: hepatomegaly, oedema
  • Heart rate typically >220 beats/min
  • Healthy infants can tolerate rates approaching 300 bpm for a time, but if untreated SVT produces signs of CHF and shock

Older Children

  • Palpitations
  • Difficulty breathing / chest discomfort
  • Syncope (if rate high enough to impair cardiac filling)
  • Heart rate typically >180 beats/min

ECG Features

Wide-complex SVT at ~270 bpm in an infant with Ebstein anomaly - Rosen's Emergency Medicine
ECG: Wide-complex SVT at ~270 bpm in an infant with Ebstein anomaly (Rosen's Emergency Medicine, Fig. 165.10)

Key ECG findings in SVT:

  • Rate: >220 bpm in infants; >180 bpm in children
  • Rhythm: Regular, no beat-to-beat variability (constant R-R intervals)
  • P waves: Absent or retrograde (buried in QRS or ST segment)
  • Narrow QRS complex (orthodromic) or wide QRS complex (antidromic, WPW, or bundle branch block)

Differentiating SVT from Sinus Tachycardia

FeatureSinus TachycardiaSVT
Precipitating eventsDehydration, fever, painNo precipitating event
P waves on ECGPresentAbsent
Heart rate varies with activityYesNo
Beat-to-beat variabilityYesConstant R-R intervals
Rate in infantsUsually <220 bpmUsually >220 bpm
Rate in childrenUsually <180 bpmUsually >180 bpm
Tip: If vagal maneuvers slow the rate and P waves become visible, the diagnosis is sinus tachycardia. Important causes of sustained sinus tachycardia to exclude: dehydration, fever, pain, haemorrhage, hyperthyroidism, sepsis, drug toxicity.

WPW Syndrome - Key Points (Nelson's)

  • Most common form of ventricular preexcitation in children
  • Accessory pathway = thin strands of subendocardial tissue that "bypass" the AV node
  • Some pathways are bidirectional; others are unidirectional
  • "Concealed" pathways: conduct only retrograde - not visible on resting ECG but can trigger SVT
  • ECG features during sinus rhythm: short PR interval + delta wave
  • Familial autosomal dominant inheritance described; most cases sporadic

Management

Step 1 - Haemodynamically UNSTABLE (altered consciousness, hypotension, pallor, cyanosis, delayed cap refill)

  • Immediate synchronized cardioversion
    • Initial dose: 0.5-1 J/kg
    • If no conversion: double to 2 J/kg
  • No time for vagal maneuvers or adenosine in an unstable child

Step 2 - Haemodynamically STABLE

A. Vagal Maneuvers (first line)

  1. Ice to face (diving reflex) - most useful in infants; apply ice bag/cold water-soaked cloth to forehead, eyes, bridge of nose for 10-15 seconds (do NOT occlude airway; do NOT apply ocular pressure)
  2. Valsalva maneuver - exhale forcefully against closed glottis for 10-15 sec (suitable for older children)
  3. Modified Valsalva - semi-recumbent at 45°, perform Valsalva, then immediately supine with 15-sec passive leg raise at 45° (higher success rate)
  4. Carotid sinus massage - less effective in children; not recommended in infants; avoid if prior stroke/carotid disease

B. Adenosine (drug of choice if vagal maneuvers fail)

Given as rapid IV/IO push over 1-2 seconds, followed immediately by normal saline flush:
AgeInitial doseSecond doseMax single dose
Neonate0.05-0.1 mg/kgIncrease by 0.05-0.1 mg/kg q2 min0.3 mg/kg
Child0.1 mg/kg (max 6 mg)0.2 mg/kg (max 12 mg)12 mg
Adolescent (≥50 kg)6 mg12 mg12 mg
  • Half-life: <10 seconds - must be pushed rapidly and flushed
  • Side effects: transient asystole, facial flushing, dyspnea, chest pain, headache, bronchospasm (avoid/use caution in asthmatics)
  • Contraindicated: 2nd/3rd degree AV block, sick sinus syndrome (unless pacemaker in place)
  • Drug interactions: methylxanthines (caffeine, theophylline) decrease effect; carbamazepine/dipyridamole increase toxicity; use with caution with digoxin

C. If adenosine fails - Elective cardioversion with procedural sedation

D. Amiodarone

  • Loading dose: 5 mg/kg IV over 20-60 minutes
  • Used for adenosine-refractory SVT or WPW with pre-excitation

Step 3 - Long-term Suppression / Prophylaxis

  • Beta-blockers (propranolol, atenolol) - first-line for recurrent SVT
  • Flecainide or sotalol for refractory cases
  • Radiofrequency catheter ablation - definitive cure; indicated for recurrent, refractory SVT or high-risk WPW

Complications (if untreated)

  • Congestive heart failure
  • Cardiogenic shock
  • Sudden cardiac death (rare - mainly in WPW with antegrade pre-excitation and rapid conduction to ventricles)

Summary Mnemonics

SVT in peds = "Fast, Fixed, No P"
  • Fast (>220 infants, >180 children)
  • Fixed rate (no variability)
  • No visible P waves
Management = "Vagal → Adenosine → Shock (if unstable: Shock first)"

Sources: Rosen's Emergency Medicine (Paediatric Cardiac section, Fig. 165.10-165.13, Table 165.5); The Harriet Lane Handbook 23rd ed. (Chapter 1, Cardiovascular Procedures; Adenosine dosing); Tintinalli's Emergency Medicine (Paediatric SVT chapter)

Management in flowchart diagram with image

Generating Image

A detailed medical flowchart diagram titled "Management of Supraventricular Tachycardia (SVT) in Paediatrics" based on Nelson's Textbook guidelines. The flowchart should be clean, professional, and easy to read with the following structure: START: "Child presents with SVT - Heart rate >220 bpm (infant) or >180 bpm (child), No beat-to-beat variability, Absent P waves" First decision diamond: "Haemodynamically STABLE?" LEFT branch (NO - Unstable): Red/orange color coding - "Signs of instability: Altered consciousness, Hypotension, Pallor/Cyanosis, Delayed capillary refill" - Action box: "IMMEDIATE SYNCHRONIZED CARDIOVERSION - Initial: 0.5-1 J/kg - If no conversion: Double to 2 J/kg" - Arrow to "Converted to Sinus Rhythm?" RIGHT branch (YES - Stable): Green color coding - Step 1 box: "VAGAL MANEUVERS - Infants: Ice to face (diving reflex) 10-15 sec - Older children: Valsalva maneuver - Modified Valsalva + leg raise" - Arrow: "SVT persists?" - Step 2 box: "ADENOSINE (rapid IV push + NS flush) - Neonate: 0.05-0.1 mg/kg - Child: 0.1 mg/kg (max 6mg), repeat 0.2 mg/kg (max 12mg) - Adolescent ≥50kg: 6mg, then 12mg" - Arrow: "SVT persists?" - Step 3 box: "ELECTIVE CARDIOVERSION (with procedural sedation) OR AMIODARONE 5 mg/kg IV over 20-60 min" Both paths converge at: "Converted to Sinus Rhythm - YES" - Final box: "LONG-TERM PROPHYLAXIS - Beta-blockers (propranolol/atenolol) - Flecainide or Sotalol (refractory) - Radiofrequency catheter ablation (definitive cure)" Bottom note box: "Caution with Adenosine: Contraindicated in 2nd/3rd degree AV block, Sick sinus syndrome. Side effects: transient asystole, flushing, bronchospasm" Use color coding: Red for unstable pathway, Green for stable pathway, Blue for drug boxes, Purple for long-term management. Include small ECG waveform icons to illustrate narrow vs wide complex SVT. Professional medical illustration style with clear arrows and decision points.

SVT Management Flowchart in Paediatrics

Here is the complete SVT management flowchart in paediatrics. The key decision points are:
Entry point: Child with HR >220 bpm (infant) or >180 bpm (child), fixed rate, absent P waves

Haemodynamically UNSTABLE (Red pathway)

Signs: altered consciousness, hypotension, pallor, cyanosis, delayed cap refill
  • Immediate synchronized cardioversion - 0.5-1 J/kg → if fails → 2 J/kg
  • Do NOT waste time on vagal maneuvers or adenosine

Haemodynamically STABLE (Green pathway)

Step 1 - Vagal maneuvers
  • Infants: Ice to face (diving reflex), 10-15 sec
  • Older children: Valsalva / Modified Valsalva + leg raise
Step 2 - Adenosine (if vagal maneuvers fail)
  • Neonate: 0.05-0.1 mg/kg rapid IV push
  • Child: 0.1 mg/kg (max 6 mg) → 0.2 mg/kg (max 12 mg)
  • Adolescent ≥50 kg: 6 mg → 12 mg
Step 3 - If adenosine fails
  • Elective cardioversion under procedural sedation, OR
  • Amiodarone 5 mg/kg IV over 20-60 min

Long-term prophylaxis (Purple pathway)

  • Beta-blockers (propranolol / atenolol) - first line
  • Flecainide or sotalol for refractory cases
  • Radiofrequency catheter ablation - definitive cure for recurrent/high-risk SVT
This is a shared conversation. Sign in to Orris to start your own chat.